QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

VRDN

QT65Viridian Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
16.63
-0.08-0.48%
OverviewShort InterestFilings
VRDNQT65Viridian Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
16.63-0.48%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 03, 2026Jun 03, 20268-KCurrent report
May 28, 2026May 28, 20268-KCurrent report
May 26, 2026May 26, 20268-KCurrent report
May 15, 2026May 15, 2026SC 13GBeneficial ownership statement (passive)
May 13, 2026May 13, 20264Statement of changes in beneficial ownership
May 13, 2026May 13, 2026SC 13D/ASC 13D/A
May 11, 2026May 11, 20268-KCurrent report
May 08, 2026May 08, 2026424B5424B5
May 08, 2026May 08, 2026424B5424B5
May 08, 2026May 08, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026May 07, 2026305B2305B2
May 07, 2026May 07, 2026FWPFWP
May 07, 2026May 07, 2026FWPFWP
May 06, 2026May 06, 2026424B5424B5
May 06, 2026May 06, 2026424B5424B5
May 05, 2026May 05, 20268-KCurrent report
May 05, 2026May 05, 20268-KCurrent report
May 05, 2026May 05, 202610-QQuarterly report
May 05, 2026May 05, 2026FWPFWP
Apr 17, 2026Apr 17, 2026ARSARS
Apr 17, 2026Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 17, 2026Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Mar 30, 2026Mar 30, 20268-KCurrent report
Mar 27, 2026Mar 27, 2026SC 13G/ASC 13G/A
Mar 09, 2026Mar 09, 20264/A4/A
#1 / 25 of 309
Page
▼
/ 13